Valuation: Ainos, Inc.

Market Cap 4.58M 4.09M 3.75M 3.41M 6.4M 433M 6.52M 44.8M 18.06M 229M 17.18M 16.82M 723M P/E 2024
-0.29x
P/E 2025 -0.47x
Enterprise Value 15.16M 13.54M 12.42M 11.3M 21.18M 1.44B 21.61M 148M 59.8M 758M 56.9M 55.69M 2.39B EV / Sales 2024
701x
EV / Sales 2025 162x
Free-Float
25.12%
Yield 2024 *
-
Yield 2025 -
1 day-1.37%
1 week-20.77%
Current month-1.37%
1 month-54.18%
3 months-53.38%
6 months-63.95%
Current year-62.20%
1 week 0.56
Extreme 0.5601
0.82
1 month 0.56
Extreme 0.5601
1.37
Current year 0.56
Extreme 0.5601
3.88
1 year 0.56
Extreme 0.5601
3.88
3 years 0.56
Extreme 0.5601
21.45
5 years 0.56
Extreme 0.5601
450
10 years 0.56
Extreme 0.5601
1,781.25
Manager TitleAgeSince
Chief Executive Officer 56 2021-04-14
Director of Finance/CFO 54 2024-03-14
Director TitleAgeSince
Director/Board Member 49 2021-04-14
Director/Board Member 54 2021-04-14
Director/Board Member 42 2021-04-14
Date Insider Type Main position Quantity % Market Cap. Importance
6/3/26 Buy

Director

2,000 0.0286%
5/28/26 Buy

Director

250 0.0036%
5/27/26 Buy

Director

2,000 0.0286%
Change 5-day change 1-year change 3-year change Capi.($)
-1.37%-20.77%-81.21%-95.90% 4.64M
-2.06%-0.33%+20.31%+52.52% 258B
-1.83%-2.15%+5.85%+18.13% 163B
+1.12%-3.27%-18.23%+57.21% 150B
+5.57%-2.76%-56.00%-15.61% 60.84B
+1.19%+2.62%-10.64%-8.42% 53.31B
+1.36%+2.98%+13.11%+42.32% 53.03B
-1.90%-3.51%+5.43%+61.66% 50.67B
-1.65%-2.26%+17.51%+64.63% 49.3B
-2.85%-1.41%+28.58%+83.18% 45.46B
Average -0.24%-3.05%-7.53%+25.97% 88.4B
Weighted average by Cap. -0.56%-1.28%+2.97%+40.76%

Financials

2024 2025
Net sales 20.73K 18.51K 16.98K 15.45K 28.96K 1.96M 29.54K 203K 81.77K 1.04M 77.8K 76.14K 3.27M 124K 111K 102K 92.53K 173K 11.75M 177K 1.21M 490K 6.2M 466K 456K 19.6M
Net income -14.86M -13.27M -12.18M -11.08M -20.77M -1.41B -21.18M -145M -58.63M -743M -55.78M -54.59M -2.35B -14.77M -13.19M -12.1M -11.01M -20.64M -1.4B -21.05M -145M -58.26M -738M -55.44M -54.26M -2.33B
Net Debt 8.11M 7.24M 6.64M 6.04M 11.33M 768M 11.55M 79.33M 31.98M 405M 30.43M 29.78M 1.28B 10.58M 9.45M 8.67M 7.89M 14.79M 1B 15.08M 104M 41.74M 529M 39.72M 38.87M 1.67B
Projected Income Statement - Annual - Ainos, Inc.
Logo Ainos, Inc.
Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Employees
41
Date Price Change Volume
26-11-02 $0.6200 -1.37% 23,500
26-10-30 $0.6286 -13.77% 30,559
26-10-29 $0.7290 -10.09% 60,639
26-10-28 $0.8109 +2.05% 4,272
26-10-27 $0.7946 +1.55% 5,334
  1. Stock Market
  2. Stocks
  3. AIMD Stock